Technology | June 22, 2012

Bayer Launches Medrad Mark 7 Arterion Angiography Injection System


June 22, 2012 — Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion Injection System, the latest in the Medrad Mark series of angiographic injectors.

The system is light and maneuverable with features that are meant to simplify the delivery of contrast media used in angiograms to determine the extent of arterial blockage.

The first Medrad Mark injector was introduced for use in angiograms more than 40 years ago. The Arterion injection system joins the company’s portfolio of interventional devices used to restore blood flow — providing physicians a complimentary line of products to diagnose and treat cardiovascular disease.

For more information: www.bayerhealthcare.com

 

 

 

Related Content

News | Contrast Media Injectors

May 3, 2016 — The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 ...

Home May 03, 2016
Home
Technology | Contrast Media Injectors

October 1, 2015 — Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline ...

Home October 01, 2015
Home
Feature | Contrast Media Injectors | Raissa Rocha and Dave Fornell

There have been several recent advances with contrast media injector technology, including cutting costs by reducing ...

Home February 10, 2015
Home
Feature | Contrast Media Injectors | Dave Fornell

Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality ...

Home July 08, 2010
Home
Subscribe Now